Gregory Scott Stein
Tulane University is actively seeking commercial entities to further develop and commercialize a novel method of producing mesenchymal stem cells (MSCs) that can be stored and used to predictably enhance or inhibit inflammation.
This technology has been tested extensively by in vitro assays and in several mouse models with success. Laboratory work is ongoing for further data and to ensure scalability.
Tulane Technology Transfer and Intellectual Property Development, New Orleans, LA 70112 504-988-6962 email@example.com